Michael A. Sherman
Chief Financial Officer, ENDOCYTE INC.
Companies
- Aktis Oncology, Inc.Board member Jan 8, 2026 to now1
- Werewolf Therapeutics, Inc.Board member May 28, 2021 to now2
- Chimerix (United States)Board member Apr 9, 2019 to now3
- Chimerix (United States)Chief executive officer Apr 9, 2019 to Aug 1, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Chimerix (United States)0 shares4Apr 21, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 21, 2025Returned to company 233,413 shares at $8.55 of Chimerix (United States)4
- Apr 21, 2025Returned to company 102,995 shares at $8.55 of Chimerix (United States)4
- Apr 21, 2025Returned to company 87,000 shares at $8.55 of Chimerix (United States)4
- May 12, 2023Bought 75,015 shares at $1.12 of Chimerix (United States)5
- May 12, 2023Bought 11,985 shares at $1.13 of Chimerix (United States)5
- Jan 17, 2023Granted 92,950 shares of Chimerix (United States)6
- Jul 25, 2022Exercised options 100,000 shares at $2.09 of Chimerix (United States)7
- Jul 25, 2022Exercised options 100,000 shares at $2.09 of Chimerix (United States)8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAktis Oncology, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed May 16, 2023
- 6SEC EDGARForm 4 filed Jan 19, 2023
- 7SEC EDGARForm 4 filed Jul 27, 2022
- 8SEC EDGARForm 4 filed Jul 26, 2022